The rapidly evolving landscape of biomarker testing in non–small cell lung cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22334
Abstract: Paul A. VanderLaan serves as the director of cytopathology and the director of thoracic pathology at the Beth Israel Deaconess Medical Center, and is an associate professor of pathology at Harvard Medical School. His clinical… read more here.
Keywords: evolving landscape; pathology; landscape biomarker; rapidly evolving ... See more keywords